Pharmacologic insights into the future of trastuzumab

A combination of factors has been responsible for improvements in cancer survival and cure rates. In addition to new therapies with novel/genetic targets, these include improvements in drug delivery, new schedules/sequencing of drug administration and the identification of combination therapies with...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of oncology 2001, Vol.12, p.43-47
Hauptverfasser:	LEYLAND-JONES, B, ARNOLD, A, GELMON, K, VERMA, S, AYOUB, J.-P, SEIDMAN, A, DIAS, R, HOWELL, J, RAKHIT, A
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal - pharmacokinetics Antibodies, Monoclonal, Humanized Antineoplastic agents Antineoplastic Agents - administration & dosage Antineoplastic Agents - pharmacokinetics Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Breast Neoplasms - drug therapy Breast Neoplasms - pathology Clinical Trials as Topic Female Humans Immunotherapy Injections, Intravenous Injections, Subcutaneous Medical sciences Pharmacology. Drug treatments Survival Analysis Trastuzumab Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!